Drug
Olanzapine Hydrochloride
Olanzapine Hydrochloride is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
3
50%
Ph phase_1
1
17%
Ph phase_3
2
33%
Phase Distribution
1
Early Stage
0
Mid Stage
5
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
3(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (16.7%)
Phase 32 (33.3%)
Phase 43 (50.0%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_4
Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia
NCT00485823
completedphase_4
Weight Gain Management in Patients With Schizophrenia
NCT00486005
completedphase_3
Olanzapine Versus Comparator in the Treatment of Bipolar Disorder
NCT00485680
completedphase_1
Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia
NCT00485810
completedphase_4
Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics
NCT00485498
Clinical Trials (6)
Showing 6 of 6 trials
NCT00485823Phase 4
Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia
NCT00486005Phase 4
Weight Gain Management in Patients With Schizophrenia
NCT00485680Phase 3
Olanzapine Versus Comparator in the Treatment of Bipolar Disorder
NCT00485810Phase 1
Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia
NCT00485498Phase 4
Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics
NCT00485901Phase 3
Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6